Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Wistuba

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Science Translational Medicine|November 10, 2017
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockersMonique B Nilsson, Huiying Sun, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefitHartmut Koeppen, Wei Yu, Jiping Zha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver studyErik Thunnissen, Masayuki Noguchi, Seena Aisner, et al.
The American Journal of Surgical Pathology|February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 CasesMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant GliomaFrederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Nature Cancer|February 1, 2021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerC Allison Stewart, Carl M Gay, Yuanxin Xi, et al.
Nature Communications|September 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Research Square|January 29, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez Ruiz, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Science Translational Medicine|November 10, 2017
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockersMonique B Nilsson, Huiying Sun, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefitHartmut Koeppen, Wei Yu, Jiping Zha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver studyErik Thunnissen, Masayuki Noguchi, Seena Aisner, et al.
The American Journal of Surgical Pathology|February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 CasesMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant GliomaFrederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Nature Cancer|February 1, 2021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerC Allison Stewart, Carl M Gay, Yuanxin Xi, et al.
Nature Communications|September 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Research Square|January 29, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez Ruiz, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Pageof 13